ARCHIVES

NCI To Fund 840 Competing Grants In FY 1991; No Downward Negotiations, But Careful Review

This article is from The Cancer Letter archive.

Vol. 16 No. 47 | December 7, 1990

Download PDF Visit The Full Archive

Related Articles

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

March 12, 1999

In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center

December 7, 2012

New Subcommittee Chairman Named

June 10, 1977

House Passes 2.8 Percent Increase For NCI

December 11, 2009

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

The Cancer Letter To End Print Edition In January

November 20, 2009